See What You’re Missing! - High Performance Computing Discovers Hidden Biomarkers-Jeffrey N. Peterson-01/27/2015 - 8:30am

Event Information
Event Topic: 
See What You’re Missing! - High Performance Computing Discovers Hidden Biomarkers
Event Date: 
01/27/2015 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Jeffrey N. Peterson
Event Speaker Title: 
Event Speaker Company: 
Event Speaker Bio: 

Jeffrey N. Peterson is the CEO of Target Discovery, Inc. (Palo Alto, CA), a Personalized Medicine Diagnostics company, initially focusing on high-value cancer treatment guidance applications. TDI is developing and applying proprietary proteomics tools, to identify and leverage the "missing link" in biochemical pathway control and biomarker utility: the specific modification states of proteins (isoforms). Mr. Peterson serves as Chairman of TDI's majority-owned subsidiary company Veritomyx, Inc., which couples high-performance computing with innovative signal processing strategies to provide breakthrough accuracy in peptide, protein, isoform and metabolite identification and characterization.
Mr. Peterson serves as Chairman of the Board of Pressure Biosciences, Inc. (PBIO), an innovative platform technology company utilizing extreme pressure cycling to control bio-molecular interactions, to optimize sample preparation across the range of life science R&D and diagnostic applications.

Mr. Peterson brings broad executive general management, multi-functional, multi-business and international experience to these roles. Prior to Target Discovery, he served as CEO of Sharpe, Peterson, Ocheltree & Associates, an international business development consulting firm assisting Fortune 500 and many smaller firms in business expansion and strategy. He spent 9 years in key management roles in Abbott Laboratories’ Diagnostics and International (Pharmaceuticals, Hospital Products, Nutritionals, Consumer) businesses, last serving as CEO and General Manager of Abbott South Africa, where he doubled the sales and tripled the income of this 50 year-old business in 3.5 years, during the tumult of South Africa’s political transition. He played an earlier pivotal management role in Abbott’s successful introduction and support of multiple new diagnostics instrument and reagent systems in the history-making X-System series, including the IMx (the highest global sales diagnostic system of its era).
Mr. Peterson's experience prior to Abbott included 11 years with General Electric’s Engineered Materials and Plastics businesses, spanning roles in strategic planning, business development, technology licensing, marketing/sales, operations/quality and R&D. He completed the Entrepreneurship curriculum and holds BSChE and MSChE (Chemical Engineering) degrees from MIT. He holds six issued US and many related international patents.

Mr. Peterson is Chair Emeritus of the BayBio Institute, a non-profit organization serving the regional life science community. He serves on the Board of BayBio, the trade association for the life sciences industry in Northern California, and provides regular mentorship support to the CEO and startup teams of IR2Dx and several other BayBio Fellow companies. He participated in founding and is an active leader in the Coalition for 21st Century Medicine, and in BIO's Personalized Medicine & Diagnostics Group. He often serves as a keynote, speaker or panelist on life sciences/healthcare policy, technology and workforce development matters.

Mr. Peterson has lived and worked overseas for 18 years, in the Middle East, Europe and Africa. Amongst many interests outside of his profession, Mr. Peterson is Chair Emeritus of the American International School of Johannesburg. He has served on the Board and continues to assist Myverse, a teen and collegiate personal and professional development resource, enabled with social media on web and mobile platforms. He is Past President and an active Board member of the San Carlos Tennis Club (a USTA Community Tennis Association), provided volunteer tennis coaching to train 50 new players over two years, and is an active volunteer with Bay Area Ski Bus.

Event Details
Event Details: 

Biomarker discovery, identification and characterization in proteomics and metabolomics is plagued by limitations in mass spectrometry, signal processing and identification algorithms. In need of better solutions, Target Discovery formed its Veritomyx subsidiary to bring a convergence high performance computing and state-of-the-art signal processing algorithms to bear on this challenge. Once again, convergence around and across the boundaries of disciplines yields astonishing results.